☆ 4.6 Article

Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model

ROYAL SOCIETY OPEN SCIENCE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pediatrics

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults A Systematic Review and Meta-analysis

Russell M. Viner et al.

Summary: This systematic review and meta-analysis found that children and adolescents have a 44% lower odds of secondary infection with SARS-CoV-2 compared to adults, with insufficient data to determine if children transmit the virus less than adults. Preliminary evidence suggests that children have a lower susceptibility to SARS-CoV-2 infection compared with adults, but their role in virus transmission remains unclear.

JAMA PEDIATRICS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunological characteristics govern the transition of COVID-19 to endemicity

Jennie S. Lavine et al.

Summary: The study suggests that infection-blocking immunity to SARS-CoV-2 wanes rapidly while disease-reducing immunity is long-lived. The model predicts that once reaching endemic phase, SARS-CoV-2 may become no more virulent than the common cold. However, a different outcome is predicted for an emergent coronavirus causing severe disease in children.

SCIENCE (2021)

添加到收藏夹

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes

Chadi M. Saad-Roy et al.

Summary: Given vaccine dose shortages and logistical challenges, various deployment strategies are being proposed to increase population immunity levels to SARS-CoV-2. While focusing on one dose may decrease infections in the short term, the long-term outcomes depend on the relative immune robustness of this approach. Under conditions of partial population immunity, a one-dose policy may increase the potential for antigenic evolution.

SCIENCE (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Robert Challen et al.

Summary: The study found that the mortality hazard ratio associated with infection with VOC-202012/1 compared with previously circulating variants was 1.64, indicating an increase in deaths from 2.5 to 4.1 per 1000 detected cases in comparatively low risk group of covid-19 patients in the community. This suggests that infection with VOC-202012/1 may lead to substantial additional mortality compared with previously circulating variants, impacting healthcare capacity planning and control policies.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Letter Infectious Diseases

SARS-CoV-2 incidence and vaccine escape

Robin N. Thompson et al.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study

Sam Moore et al.

Summary: The study found that vaccination alone is insufficient to contain the outbreak. Even with an optimistic assumption that the vaccine can prevent 85% of infections, the reproduction number (R) is estimated to be 1.58 once all eligible adults have been offered both doses of the vaccine without non-pharmaceutical interventions (NPIs).

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Jamie Lopez Bernal et al.

Summary: This study estimated the real-world effectiveness of Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed COVID-19 symptoms, hospital admissions, and deaths. The vaccines showed significant reduction in symptomatic COVID-19 among older adults and further protection against severe disease. Both vaccines demonstrated similar effects and protection was maintained for over 6 weeks.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Biochemical Research Methods

Modelling optimal vaccination strategy for SARS-CoV-2 in the UK

Sam Moore et al.

Summary: The COVID-19 outbreak has shown the vulnerability to novel infections and the UK, like many other countries, enforced social distancing measures to reduce transmission. Vaccination is seen as the only way to contain the infection and return to normalcy, with targeting older age groups first being considered optimal. This vaccination strategy is crucial in reducing mortality and healthcare demands, but success is dependent on vaccine characteristics and population uptake.

PLOS COMPUTATIONAL BIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination

Laura Matrajt et al.

Summary: The optimal allocation strategy for COVID-19 vaccines, whether single-dose or two-dose, depends on the transmission rate and vaccine efficacy. In low transmission scenarios, single-dose vaccination is optimal with high efficacy, while in high transmission scenarios, prioritizing older adults for two doses is the best strategy to prevent more deaths.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Immunology

Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination

Sarah Cobey et al.

Summary: When vaccines are in limited supply, expanding the number of people who receive the vaccine by dose-sparing strategies may reduce disease and mortality, although it could potentially increase the risk of vaccine-escape variants. Preliminary evidence suggests that such strategies could slow the rate of viral escape, as long as vaccination provides some protection against escape variants.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate

Ryosuke Omori et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing

Luca Ferretti et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Stephen M. Kissler et al.

SCIENCE (2020)

添加到收藏夹

Letter Medicine, General & Internal

SARS-CoV-2 Infection in Children

Xiaoxia Lu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Pediatrics

Epidemiology of COVID-19 Among Children in China

Yuanyuan Dong et al.

PEDIATRICS (2020)

添加到收藏夹

Article Infectious Diseases

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Robert Verity et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

Chadi M. Saad-Roy et al.

SCIENCE (2020)

添加到收藏夹

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Rapid review of available evidence on the serial interval and generation time of COVID-19

John Griffin et al.

BMJ OPEN (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Evolutionary emergence of infectious diseases in heterogeneous host populations

Helene Chabas et al.

PLOS BIOLOGY (2018)

添加到收藏夹

Article Infectious Diseases

Seven challenges in modeling pathogen dynamics within-host and across scales

Julia R. Gog et al.

EPIDEMICS (2015)

添加到收藏夹

Review Multidisciplinary Sciences

Unifying the epidemiological and evolutionary dynamics of pathogens

BT Grenfell et al.

SCIENCE (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.